Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 12:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 66 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Postpartum Uterine Bleeding Clear all

Conditions: Twin; Complicating Pregnancy, Postpartum Hemorrhage
Interventions: Methylergonovine, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: Up to 65 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Placenta Accreta, Postpartum Hemorrhage, Cesarean Section, Tranexamic Acid
Interventions: Tranexamic Acid, Placebo Drug; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Fresno, California

Conditions: Postpartum Hemorrhage
Interventions: Active management of the third stage of labor, Expectant management of the third stage of labor, Oxytocin and gentle cord traction with fundal massage, Oxytocin; Procedure · Drug
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 16 Years and older · Female only
Enrollment: 218 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2006
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Analgesia, Obstetrical, Coagulation Defect; Postpartum, Nonsteroidals (NSAIDs)Toxicity, Postpartum Hemorrhage, Postoperative Pain, Ketorolac Adverse Reaction, Blood Loss, Postoperative
Interventions: Ketorolac Tromethamine 30 MG/ML, Placebos; Drug
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hemophilia A, Hemophilia A, Severe, Factor VIII (FVIII), FVIII Deficiency, Carrier of Hemophilia A, Inhibitors, Pregnancy, Maternal Blood Loss, Pregnancy Complications, Bleeding Disorder, Hemorrhage, Postpartum, Alloimmunization, X-Linked
Interventions: Not listed
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Postpartum Hemorrhage
Interventions: Placental Blood Drainage, Placenta Blood Not Drained; Procedure
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Postpartum Hemorrhage, Uterine Atony
Interventions: 15-methyl prostaglandin F2α, Methylergonovine Maleate; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Postpartum Haemorrhage (PPH), PPH, Postpartum Hemorrhage (Primary)
Interventions: Alma System; Device
Lead sponsor: ResQ Medical Ltd; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Placenta Accreta, Blood Pressure, Hemorrhage, Hemorrhage, Postpartum
Interventions: LiDCO CNAP Monitoring Equipment; Device
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hemorrhage, Postpartum, Hemorrhage, Vasoconstriction
Interventions: AccuFlow sensor, Survey; Device · Other
Lead sponsor: Megan Lord; Other
Eligibility: 18 Years and older · Female only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Postpartum Hemorrhage
Interventions: Jada® System; Device
Lead sponsor: Alydia Health; Industry
Eligibility: Female only
Enrollment: 809 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 16
States / cities: Loma Linda, California • Newark, Delaware • Gainesville, Georgia + 11 more

Conditions: Postpartum Hemorrhage
Interventions: blood loss estimation; Procedure
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Postpartum Hemorrhage, Postpartum Preeclampsia, Postpartum Sepsis, Postpartum Depression, Patient Empowerment, Patient Education, Postpartum Care
Interventions: Video Education; Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Post-partum Hemorrhage (PPH)
Interventions: Not listed
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Hackensack, New Jersey

Conditions: Postpartum Hemorrhage, Postsurgical Bleeding, Abdominal Ultrasound, FAST Scan, Non-invasive Hemoglobin Measurement
Interventions: FAST scan and non-invasive hemoglobin measurement; Device
Lead sponsor: Northwestern University; Other
Eligibility: 12 Years to 60 Years · Female only
Enrollment: 105 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Postpartum Hemorrhage, Immediate
Interventions: Intrauterine balloon tamponade; Device
Lead sponsor: Denver Health and Hospital Authority; Other
Eligibility: 18 Years to 55 Years · Female only
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Postpartum Hemorrhage
Interventions: oxytocin, Shore durometer; Drug · Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Blood Loss Massive, Post Partum Hemorrhage
Interventions: Quantra Hemostasis Analyzer with the QStat Cartridge; Diagnostic Test
Lead sponsor: HemoSonics LLC; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 296 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 6
States / cities: Rochester, New York • Columbus, Ohio • Oklahoma City, Oklahoma + 3 more

Conditions: Postpartum Hemorrhage
Interventions: Sublingual Misoprostol, IV Oxytocin; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,358 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Postpartum Hemorrhage
Interventions: Initiation of standard postpartum oxytocin immediately following fetal shoulder delivery, Initiation of standard postpartum oxytocin immediately following placenta delivery, Saline Placebo; Other
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 104 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Obstetric Complication, Postpartum Hemorrhage, Postpartum Endometritis
Interventions: CeFAZolin 1000 MG, Clindamycin 900 MG in 6 ML Injection; Drug
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Wound; Rupture, Surgery, Cesarean Section, Postpartum Hemorrhage, Surgery
Interventions: Hemoleven; Biological
Lead sponsor: Laboratoire français de Fractionnement et de Biotechnologies; Industry
Eligibility: 6 Months and older
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Postpartum Uterine Bleeding
Interventions: Not listed
Lead sponsor: Glenveigh Medical; Industry
Eligibility: Female only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 11
States / cities: Phoenix, Arizona • Denver, Colorado • Orlando, Florida + 7 more

Conditions: Postpartum Period, Depression, Stress Disorders, Post-Traumatic
Interventions: Not listed
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

Prophylactic Methylergonovine for Twin Cesarean

Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study

Active Versus Expectant Management of the Third Stage of Labor

IV Ketorolac on Platelet Function Post-Cesarean Delivery

Hemophilia A Research Program

The Effect of Placental Cord Drainage on Postpartum Blood Loss

Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial

EVE TRIAL , ALMA SYSTAM

CNAP vs IABP in Pregnant Women With Placenta Accreta

A Pilot Study to Assess the Feasibility and Tolerability of the AccuFlow Perfusion Sensor for Intrapartum Hemorrhage

RUBY Post-Market Registry on the Jada® System

Accuracy of Blood Loss Estimation After Vaginal Delivery

Postpartum Video Education

Accurate Display of Postpartum Hemorrhage Using Triton (ADOPT)

Abdominal Ultrasound Assessment in the Post-cesarean Patient

Minimum Effective Duration of Intrauterine Balloon Tamponade for the Management of Postpartum Hemorrhage

Pharmacokinetics of Oxytocin at Cesarean Delivery

QStat Cartridge in Obstetric Patients

Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping

Antibiotics During Intrauterine Balloon Tamponade Placement

HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency

Belfort Dildy- Obstetrical Tamponade System Post-Marketing Surveillance Program

Relationship Between Postpartum Mood Disorders and Delivery Experience